Results 231 to 240 of about 97,591 (248)

Meropenem

Reactions Weekly, 2014
openaire   +2 more sources

Meropenem

Drugs, 2012
Katherine A Lyseng-Williamson
exaly   +2 more sources

Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial

Lancet Infectious Diseases, The, 2021
Richard G Wunderink, Mari Ariyasu, Philippe Clevenbergh   +2 more
exaly  

Early Experience With Meropenem-Vaborbactam for Treatment of Carbapenem-resistant Enterobacteriaceae Infections

Clinical Infectious Diseases, 2020
Ryan K Shields, Erin K Mccreary, Liang Chen   +2 more
exaly  

Meropenem

Reactions Weekly, 2019
  +4 more sources

Meropenem/vaborbactam: a next generation β-lactam β-lactamase inhibitor combination

Expert Review of Anti-Infective Therapy, 2020
Andrea Novelli, Gian Maria Rossolini, Mario Tumbarello   +2 more
exaly  

Effect of Empirical Treatment With Moxifloxacin and Meropenem vs Meropenem on Sepsis-Related Organ Dysfunction in Patients With Severe Sepsis

JAMA - Journal of the American Medical Association, 2012
Frank Bloos, Axel Nierhaus, Armin Seibel
exaly  

A porous g-C3N4 nanosheets containing nitrogen defects for enhanced photocatalytic removal meropenem: Mechanism, degradation pathway and DFT calculation

Environmental Research, 2020
Jin Wang, Boru Gao, Mengmeng Dou
exaly  

Meropenem

Reactions Weekly, 2011
openaire   +1 more source

Meropenem-Vaborbactam Tested against Contemporary Gram-Negative Isolates Collected Worldwide during 2014, Including Carbapenem-Resistant, KPC-Producing, Multidrug-Resistant, and Extensively Drug-Resistant Enterobacteriaceae

Antimicrobial Agents and Chemotherapy, 2017
Mariana Castanheira, Michael D Huband
exaly